Skip to main content
. 2020 Apr 26;72(6):903–911. doi: 10.1002/art.41189

Figure 3.

Figure 3

Antibody response to PAD4 and proliferation of T cells in response to PAD4 in patients with RA (n = 41), patients with PsA (n = 25), and healthy controls (n = 11). Subjects were tested for antibody response to PAD4 and proliferative response to PAD4 and classified into the following 4 groups: negative for PAD4 antibody (Ab−) and positive for T cell proliferation (Tc+), positive for both PAD4 antibody and T cell proliferation, negative for both PAD4 antibody and T cell proliferation, or positive for PAD4 antibody and negative for T cell proliferation. Values are the number of shared epitope (SE)–positive subjects/total number of subjects in the indicated group. See Figure 1 for other definitions.